Cellular Processing of Copper-67-labeled Monoclonal Antibody chCE7 by Human Neuroblastoma Cells

Cancer Research

Volumn 55, Issue 1, 1995, Pages 46-50

  Novak Hofer, Ilse ^a   Amstutz, Hans Peter ^c   Mäcke, Helmut R ^b   Schwarzbach, Rolf ^a   Zimmermann, Kurt ^a   Morgenthaier, Jean Jacques ^c   Schubiger, P August ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Central Laboratory in Bern   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COPPER 67; IODINE 125; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CHCE 7; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEGRADATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; NEUROBLASTOMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; COPPER RADIOISOTOPES; ENDOCYTOSIS; HUMAN; IMMUNOCONJUGATES; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0028909164     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Waldmann, T. A. Monoclonal antibodies in diagnosis and therapy. Science (Washington DC), 252: 1657–1662, 1991.
2. Grossbard, M. L., Press, O. W., Appelbaum, F. R., Bernstein, I. D., and Nadler, L. M. Monoclonal antibody-based therapies of leukemia and lymphoma. Blood, 80: 863–878, 1992.
3. Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., Matthews, D. C., Fisher, L. D., and Bernstein, I. D. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med., 329: 1219–1224, 1993.
4. Breitz, H. B., Weiden, P. W., Vanderheyden, J. L., Appelbaum, J. W., Björn, M. J., Fer, M. F., Wolf, S. B., Ratliff, B. A., Seiler, C. A., Foisie, D. C., Fisher, D. R., Schroff, R. W., Fritzberg, A. R., and Abrams, P. G. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. J. Nucl. Med., 33: 1099–1112, 1992.
5. Deshpande, S. V., De Nardo, S. J., Kukis, D. L., Moi, M. K., Mc Call, M. J., De Nardo, G. L., and Meares, C. F. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J. Nucl. Med., 31: 473–479, 1990.
6. De Nardo, G. L., De Nardo, S. J., Meares, C. F., Kukis, D., Diril, H., Mc Call, M., Adams, G. P., Mausner, L. F., Moody, D. C., and Deshpande, S. V. Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and in patients with lymphoma. Antibody Immunoconj. Radiopharm., 4: 777–785, 1991.
7. 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. Cancer Res., 43: 5347–5355, 1983.
8. Halpern, S., Haindl, W., Beauregard, R. N., Hagan, P., Clutter, M., Amox, D., Merchant, B., Unger, M., Mongovi, C., Bartholomew, R., Ine, R., Carlo, D., and Dillman, R. Scintigraphy with In-111-labeled monoclonal antibodies: kinetics, biodistribution and tumor detection. Radiology, 168: 529–536, 1988.
9. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. Development of a stable radioio-dinating agent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med., 30: 216–226, 1989.
10. Geissler, F., Anderson, S. K., and Press, O. W. Intracellular catabolizm of radiolabeled anti-CD3 antibodies by leukemic T-cells. Cell. Immunol., 137: 96–110, 1991.
11. Press, O. W., De Santes, K., Anderson, S. A., and Geissler, F. Inhibition of catabolism of radiolabeled antibodies in tumor cells using lysosomotropic amines and carboxylic ionophores. Cancer Res., 50: 1243–1250, 1990.
12. 125I radiolabeled T101 anti-CD5 monoclonal antibody. Nucl. Med. Biol., 17: 201–207, 1990.
13. Novak-Hofer, I., Amstutz, H., Morgenthaier, J. J., and Schubiger, P. A. Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells. Int. J. Cancer, 57: 427–432, 1994.
14. Amstutz, H., Rytz, Ch., Novak-Hofer, I., Spycher, M., Schubiger, P. A., Blaser, K., and Morgenthaier, J. J. Production and characterization of a mouse/human chimeric antibody directed against human neuroblastoma. Int. J. Cancer, 53: 147–152, 1993.
15. Novak-Hofer, I., Amstutz, H., Haldemann, A., Blaser, K., Morgenthaier, J. J., Bläuenstein, P., and Schubiger, P. A. Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. J. Nucl. Med., 33: 231–236, 1992.
16. Dörr, U., Haldemann, A. R., Leibundgut, K., Novak-Hofer, I., Amstutz, H., Wagner, H. P., Schubiger, P. A., Morgenthaier, J. J., Rösier, H., Schilling, F. H., Kscielniak, E., Treuner, J., and Bilh, H. First clinical results with the chimeric antibody chCE7 in neuroblastoma. Targeting features and biodistribution data. Eur. J. Nucl. Med., 20: 858, 1993.
17. Duncan, J. R., and Welch, M. J. Intracellular metabolism of indium-lll-DTPA-labeled receptor targeted proteins. J. Nucl. Med., 34: 1728–1738, 1993.
18. Motta-Hennessy, C., Sharkey, R. M., and Goldenberg, D. M. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J. Nucl. Med., 31: 1510–1519, 1990.
19. Smith-Jones, P. M., Fridrich, R., Kaden, T. A., Novak-Hofer, I., Siebold, K., Tschudin, D., and Mäcke, H. R. Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(l,4,8,ll-tetraazacyclotetradec-l-yl)-methyl] benzoic acid. Bioconjugate Chem., 2: 415–421, 1991.
20. 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb 35. Cancer Res., 53: 5727–5733, 1993.
21. Anderson, C. J., Connett, J. M., Schwarz, S. W., Rocque, P. A., Guo, L. W., Philpott, G. W., Zinn, K. R., Meares, C. F., and Welch, M. J. Copper-64-labeled antibodies for PET imaging. J. Nucl. Med., 33: 1685–1691, 1992.
22. 2+ complex towards amide formation and its use as a protein-labeling agent. Helv. Chim. Acta., 73: 149–153, 1990.
23. Meares, C. F., Mc Call, M. J., Reardan, D. T., Goodwin, D. A., Diamanti, C. I., and Mc Tigue, M. Conjugation of antibodies with bifunctional chelating agents: isothio-cyanate and bromoacetamide reagents, methods of analysis and subsequent addition of metal ions. Anal. Biochem., 142: 68–78, 1984.
24. Poole, B., and Ohkuma, S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell. Biol., 90: 665–669, 1981.
25. Deacon, J. M., Wilson, P. A., and Peckham, J. The radiobiology of neuroblastoma. Radiother. Oncol., 3: 201–209, 1985.
26. Langmuir, V. K. Radioimmunotherapy: clinical results and dosimetric considerations. Nucl. Med. Biol., 19: 213–224, 1992.
27. Schott, M. E., MUenic, D. E., Yokota, T., Whitlow, M., Wood, J. F., Fordyce, W. A., Cheng, R. C., and Schlom, J. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res., 52: 6413–6417, 1992.